FLGT

FLGT

USD

Fulgent Genetics Inc. Common Stock

$22.880-0.060 (-0.262%)

Real-time Price

Healthcare
Diagnostics & Research
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$22.940

High

$23.100

Low

$22.631

Volume

0.01M

Company Fundamentals

Market Cap

700.3M

Industry

Diagnostics & Research

Country

United States

Trading Stats

Avg Volume

0.22M

Exchange

NGM

Currency

USD

52-Week Range

Low $14.57Current $22.880High $24.64

Related News

Analyst Upgrades

UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30

UBS analyst Lu Li upgrades Fulgent Genetics from Neutral to Buy and raises the price target from $20 to $30.

View more
UBS Upgrades Fulgent Genetics to Buy, Raises Price Target to $30
Analyst Upgrades

Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $21

Piper Sandler analyst David Westenberg maintains Fulgent Genetics with a Neutral and lowers the price target from $23 to $21.

View more
Piper Sandler Maintains Neutral on Fulgent Genetics, Lowers Price Target to $21
Earnings Call Transcripts

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript

View more
Fulgent Genetics, Inc. (FLGT) Q2 2025 Earnings Call Transcript
BusinessWire

Fulgent Reports Second Quarter 2025 Financial Results

Core Revenue of $81.7 million grows 16% year-over-year Raising Full Year 2025 Core Revenue Guidance to $320 million GAAP gross profit of $34.4 million, or GAAP gross margin of 42.1%; Non-GAAP gross profit of

View more
Fulgent Reports Second Quarter 2025 Financial Results